These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7922429)

  • 1. Persistent paralysis in critically ill patients after the use of neuromuscular blocking agents.
    Hoyt JW
    New Horiz; 1994 Feb; 2(1):48-55. PubMed ID: 7922429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applied pharmacology of common neuromuscular blocking agents in critical care.
    Prielipp RC; Coursin DB
    New Horiz; 1994 Feb; 2(1):34-47. PubMed ID: 7922428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paralysis after long-term administration of neuromuscular blocking agents].
    Sugai N
    Masui; 1992 Jan; 41(1):2-10. PubMed ID: 1545497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care.
    Armstrong DK; Crisp CB
    New Horiz; 1994 Feb; 2(1):85-93. PubMed ID: 7922434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should ICU patients receive muscle relaxants?
    Coakley J
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1644-8. PubMed ID: 8858758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of neuromuscular blockade in the critically ill patient.
    Burry L; HoSang M; Hynes-Gay P
    Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of sedation and critical illness.
    Foster J
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):287-96. PubMed ID: 16115537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular blockade in adult intensive care.
    Topulos GP
    New Horiz; 1993 Aug; 1(3):447-62. PubMed ID: 7922424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sedation and paralysis.
    Piriyapatsom A; Bittner EA; Hines J; Schmidt UH
    Respir Care; 2013 Jun; 58(6):1024-37. PubMed ID: 23709198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged paralysis after neuromuscular junction blockade: case reports and electrodiagnostic findings.
    Gooch JL; Moore MH; Ryser DK
    Arch Phys Med Rehabil; 1993 Sep; 74(9):1007-11. PubMed ID: 8379831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular blockade: indications, peripheral nerve stimulation, and other concurrent interventions.
    Davidson JE
    New Horiz; 1994 Feb; 2(1):75-84. PubMed ID: 7922432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
    Kleinpell R; Bedrosian C; McCormick L; Kremer M; Bujalski L; Bronsted R
    Am J Crit Care; 1996 Nov; 5(6):449-54. PubMed ID: 8922161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a policy for patients receiving neuromuscular blocking agents.
    Earl G; McMahon MB; Bartley M; Mancini W; Becker S
    J Trauma Nurs; 1997; 4(3):76-81. PubMed ID: 9407819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular blocking agents: enhancing safety by reducing the risk of accidental administration.
    Koczmara C; Jelincic V
    Dynamics; 2007; 18(1):28-32. PubMed ID: 17396480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
    Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
    Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse responses: sedation, analgesia and neuromuscular blocking agents in critically ill children.
    Sorce LR
    Crit Care Nurs Clin North Am; 2005 Dec; 17(4):441-50, xi-xii. PubMed ID: 16344213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent paralysis after vecuronium administration.
    Conway EE
    N Engl J Med; 1992 Dec; 327(26):1882. PubMed ID: 1360147
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged muscle weakness after neuromuscular blockade in the intensive care unit.
    Raps EC; Bird SJ; Hansen-Flaschen J
    Crit Care Clin; 1994 Oct; 10(4):799-813. PubMed ID: 8000927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring neuromuscular blockade in the intensive care unit: the peripheral nerve stimulator.
    Rowlee SC
    Heart Lung; 1999; 28(5):352-62; quiz 363-4. PubMed ID: 10486453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.